Personal record-keeping and educational reference. 18+. The app does not recommend substances, doses or treatment, or determine whether a substance is safe, approved or appropriate for you. Consult a qualified healthcare professional about decisions involving your health.
‹ Library

CJC-1295 No DAC (Mod GRF 1-29)

Growth Hormone SecretagogueResearch Use Only

Also known as: Mod GRF 1-29, Modified GRF 1-29, CJC-1295 without DAC, Sermorelin analog

A short-acting growth-hormone-releasing peptide that mimics the body's natural GH pulses; usually taken at bedtime.

Dosing quick reference

research reference
Starting dose
100 mcg once daily (bedtime)
Frequency
Once daily (bedtime)
Typical range
100–300 mcg per day
Cycle
8–12 weeks on, then take a break
Titration (step-up)
Wk 1–2: 100 → Wk 3–4: 150 → Wk 5–6: 200 → Wk 7+: 250–300 mcg
Half-life
~30 minutes (short-acting)
Route
Subcutaneous (research)
Common use
Studied as a short-acting GHRH analog intended to mimic natural growth-hormone pulses
Common vial sizes
5 mg
Storage
Lyophilized powder stored refrigerated or frozen away from light; reconstituted solution refrigerated (2–8 °C) and used within a few weeks
Stacking notes
Frequently paired with a GHRP such as Ipamorelin or GHRP-2 for synergistic growth-hormone release in research protocols

Reported side effects

Injection-site reactionFlushing reported anecdotallyTransient tingling reported anecdotally
Regulatory note: Not an approved therapeutic; sold for research purposes only
Calculate a dose →CJC-1295 No DAC (Mod GRF 1-29) on The Peptide Guide →Deeper research reference: literature dose ranges, storage and handling, and where to source in Canada.

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Research-only labeling does not establish that a substance is safe, approved or appropriate for personal use. Consult a qualified healthcare professional about health decisions.